A new stem cell-containing bio-ink could be used to create living tissue through 3D printing, called "bio-printing." The ink was developed by scientists at the University of Bristol, and it could eventually produce complex tissues for surgical implants.
Pinpointing the cause of brain infections and inflammation is challenging, with more than half of cases going undiagnosed. But a Johns Hopkins University team is aiming to change that with next-generation sequencing.
National Parkinson's Foundation, Global Kinetics start outcomes trial with continuous movement monitor
Australia's Global Kinetics is teaming up with the National Parkinson's Foundation to study how its wrist-worn activity monitor can help in the treatment of Parkinson's patients.
Researchers have developed a small ring to be placed on the aorta to help those recovering from certain diseases or those waiting for a transplant. In those circumstances, the heart is often weakened and needs some help pumping.
The FDA has accepted one of two preclinical modules from its PMA application for Toraymyxin from Spectral Medical, the company said. This news comes soon after Spectral snagged a solid CA$10 million (US$7.1 million) in funding this past January, specifically aimed at helping the company finalize its PMA submission for FDA approval.
Q-Collars may be an answer to the effects of sport-related head collisions, according to the results of a pair of studies of high school football and hockey players at Cincinnati Children's.
A study from Kaiser Permanente found that remote monitoring and automated coaching using ResMed can "significantly improve" continuous positive airway pressure therapy compliance for patients suffering from obstructive sleep apnea.
WellDoc has released results from a study that aimed to evaluate the "feasibility and reach" of using a lay coach along with the BlueStar mobile app for those with Type 2 diabetes. The study found a large percentage of participants were engaged with the app, and many sent data generated from the app to their care team.
Johnson & Johnson has been sitting on its OneTouch Via patch-based insulin delivery system for a while now, and the tech is finally being launched. It is slated to debut the patch in limited ex-U.S. markets before year end, with a U.S. launch planned for "shortly thereafter," the company said.
Adding blue-light imaging to white-light endoscopy can give a more complete picture of the body's internal tissues, but can also be more costly, impractical and time-consuming. Vancouver, Canada-based Imagin is teaming up with the University of Rochester and the U.S. Department of Energy on a device that could eliminate these disadvantages and facilitate the early detection of bladder cancer.